BioStem director reports initial stock and RSU holdings

BioStem Technologies, Inc. director Jodi Ungrodt reported initial beneficial ownership on a Form 3.

Rhea-AI Filing Summary

BioStem Technologies, Inc. director Jodi Ungrodt reported initial beneficial ownership on a Form 3. The filing lists 5,647 Restricted Stock Units, each representing a contingent right to receive one share of common stock, and 5,648 shares of common stock, all held directly. The RSUs vest in two installments, with one tranche vesting on May 27, 2026 and the remaining tranche vesting on August 27, 2026.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider UNGRODT JODI

Role Director

Type	Security	Shares	Price	Value
holding	Restricted Stock Units F2, F1	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 5,647 contracts (Direct); Common Stock — 5,648 shares (Direct)

Footnotes (2)

1. F1. These restricted stock units vest in two installments. The first installment vested on May 27, 2026 and the remaining installment vests on August 27, 2026.
2. F2. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

Key Figures

Restricted Stock Units: 5,647 units Common stock held: 5,648 shares RSU first vesting date: May 27, 2026 +1 more

4 metrics

Restricted Stock Units 5,647 units RSUs held by Jodi Ungrodt, each convertible into one share of common stock

Common stock held 5,648 shares Direct common stock holdings following the reported date

RSU first vesting date May 27, 2026 First installment of RSUs vested on this date

RSU final vesting date August 27, 2026 Remaining RSU installment vests on this date

Key Terms

Restricted Stock Units, contingent right, beneficial ownership

3 terms

Restricted Stock Units financial

"These restricted stock units vest in two installments."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share"

beneficial ownership financial

"director Jodi Ungrodt reported initial beneficial ownership on a Form 3"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did BioStem Technologies (BSEM) disclose in this Form 3 for Jodi Ungrodt?

The Form 3 shows that director Jodi Ungrodt initially reported holdings of 5,647 Restricted Stock Units and 5,648 shares of common stock, all held directly as of the reported date.

How many Restricted Stock Units does Jodi Ungrodt hold in BSEM?

Jodi Ungrodt holds 5,647 Restricted Stock Units, each representing a contingent right to receive one share of BioStem Technologies common stock. These RSUs are reported as a direct derivative position in the filing.

How many BioStem Technologies (BSEM) common shares does Jodi Ungrodt directly own?

The filing reports that Jodi Ungrodt directly owns 5,648 shares of common stock of BioStem Technologies. This number reflects her direct common-share holdings following the reported date on the Form 3.

What is the vesting schedule of Jodi Ungrodt’s BSEM Restricted Stock Units?

The 5,647 Restricted Stock Units vest in two installments. The first installment vested on May 27, 2026, and the remaining installment is scheduled to vest on August 27, 2026, according to the footnotes.

What does each Restricted Stock Unit represent for BSEM’s Jodi Ungrodt?

Each of Jodi Ungrodt’s Restricted Stock Units represents a contingent right to receive one share of BioStem Technologies common stock, as described in the footnotes to the Form 3.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/14/2026 - 07:12 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

UNGRODT JODI

(Last) (First) (Middle)

C/O BIOSTEM TECHNOLOGIES, INC.

2836 CENTER PORT CIRCLE

(Street)

POMPANO BEACH FLORIDA 33064

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/06/2026

3. Issuer Name and Ticker or Trading Symbol
BioStem Technologies, Inc. [ BSEM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	5,648	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	(1)	Common Stock	5,647	(2)	D

Explanation of Responses:

1. These restricted stock units vest in two installments. The first installment vested on May 27, 2026 and the remaining installment vests on August 27, 2026.

2. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

	/s/ Jodi Ungrodt	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)